Identification and uptake of cervical cancer screening during active surveillance in HIV-positive women attending a primary health care facility in Tshwane District, South Africa
Article Sidebar
Main Article Content
Abstract
Cervical cancer constitutes 20 - 25% of cancers in women in Sub-Saharan Africa. It is a preventable disease, subject to adequate screening, management and follow up. Nevertheless, more than half a million women worldwide develop invasive cervical cancer annually, with middle-and low-income countries achieving only 19% of successful screening coverage compared with high-income countries (63%). The age-standardised incidence rate for cervical cancer in South Africa is 24.71 per 100 000 women.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJPH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
How to Cite
References
Akokuwebe ME, Idemudia ES, Lekulo AM, Motlogeloa OW. Determinants and levels of cervical cancer screening uptake among women of reproductive age in South Africa: Evidence from South Africa Demographic and health survey data, 2016. BMC Public Health 2021;21(1):1-4. https://doi.org/10.1186/s12889-021-12020-z
National Department of Health; 2017. Cervical cancer prevention and control policy.
https://www.westerncape.gov.za/text/2020/February/cervical_cancer_prevention_and_
control_policy.pdf (accessed 18 May 2023)
Botha MH, Dreyer G. Guidelines for cervical cancer screening in South Africa. Southern Afr
J Gynaecol Oncol 2017;9(1):8-12. https://hdl.handle.net/10520/EJC-9584c6bc7
Hopkins K, Jaffer M, Hlongwane K, et al. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa. PLOS ONE 2021;16(7):e0255124. https://doi.org/10.1371/journal.
pone.0255124
Adonis L, Basu D, Luiz J. Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa. Global Health Action 2014;7(1):23807. https://doi.org/10.3402/gha.v7.23807
MayoM,PotugariB,BzeihR,ScheidelC,CarreraC,ShellenbergerRA.Cancerscreeningduring the COVID-19 pandemic: A systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes 2021;5(6):1109-1117. https://doi.org/10.1016/j.mayocpiqo.2021.10.003
Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Preventive Med 2021;151:106596. https://doi.org/10.1016/j.ypmed.2021.106596
DucrayJF,KellCM,BasdavJ,HaffejeeF.Cervicalcancerknowledgeandscreeninguptake by marginalised population of women in inner-city Durban, South Africa: Insights into the need for increased health literacy. Women’s Health 2021;17. https://doi. org/10.1177/17455065211047141
Lieber M, Afzal O, Shaia K, Mandelberger A, Du Preez C, Marie Beddoe A. Cervical cancer screening in HIV-positive farmers in South Africa: Mixed-method assessment. Ann Glob Health 2019;85(1):58. https://doi.org/10.5334/aogh.37
Godfrey MAL, Mathenjwa S, Mayat N. Rural Zulu women’s knowledge of and attitudes towards Pap smears and adherence to cervical screening. Afr J Prim Health Care Fam Med 2019;11(1). http://dx.doi.org/10.4102/phcfm.v11i1.1994
Van Wyk AC, De Jager LJ, Razack R, Van Wyk SS, Kleinhans W, Simonds HM, Schubert PT. The initial impact of the COVID-19 pandemic on the diagnosis of new cancers at a large pathology laboratory in the public health sector, Western Cape Province, South Africa. S Afr Med J 2021;111(6):570-574. Erratum in: S Afr Med J 2021 Jun 08;111(6):13325. https:// hdl.handle.net/10520/ejc-m_samj-v111-n6-a20
Landy R, Sasieni PD, Mathews C, et al. Impact of screening on cervical cancer incidence: A population-based case–Control Study in the United States. Int J Cancer 2019;147(3):887- 896. https://doi.org/10.1002/ijc.32826